Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

64 evidence items · page 3 / 3

29.2 %Pooled HBV prevalence was 29.2% in the very high-risk group.

Kenyahépatite Bpublished 2023PLOS global public healtheurope_pmcdocument of 8 observations

100 %All 11 occult hepatitis B virus (OBI) patients were anti-HBc positive.

Kenyahépatite Bpublished 2021PloS onePubMeddocument of 7 observations

4.5 %HBV prevalence was 4.5% among those with primary level education.

Kenyahépatite Bpublished 2023PloS onePubMeddocument of 15 observations

94.2 %Among 208 HIV-infected ART-naïve adults in Kenya, 196 (94.2%) were hepatitis B surface antigen (HBsAg) negative.

Kenyahépatite B · VIH/sidapublished 2021PloS onePubMeddocument of 7 observations

4.7 %HBV prevalence was 4.7% (95% CI: 3.3–6.0%) among people living with HIV in Kenya.

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations

After six months of antiretroviral therapy follow-up, there was a significant drop in viral load for both HIV mono-infected and HIV/HBV co-infected groups at p<0.001.

Kenyahépatite B · VIH/sidapublished 2021Pan African Medical JournalOpenAlexdocument of 10 observations

6.2 %Pooled HBV prevalence was 6.2% in the high-risk group.

Kenyahépatite Bpublished 2023PLOS global public healtheurope_pmcdocument of 8 observations

71 %For hepatitis B virus (HBV) vaccine, 71% of MVA.HIVA subjects were protected compared to 92% of control subjects (p=0.05).

Kenyahépatite Bpublished 2014Vaccineeurope_pmcdocument of 10 observations

3.4 %Pooled HBV prevalence was 3.4% in the low-risk group.

Kenyahépatite Bpublished 2023PLOS global public healtheurope_pmcdocument of 8 observations

4.5 %Among pregnant women without previous test results in selected Primary Health Care facilities in Kenya, the positivity rate for hepatitis B virus (HBV) was 4.5%.

Kenyahépatite Bpublished 2024Frontiers in public healthPubMeddocument of 15 observations

4.1 %The prevalence of Hepatitis B virus infection among blood donors in Kenya was 4.1%.

Kenyahépatite Bpublished 2023Frontiers in public healthPubMeddocument of 6 observations

0.1 %HBV prevalence ranged from 0.1% in Eastern Kenya regions to over 5% in northern and western Kenya.

Kenyahépatite Bobserved 2018published 2024PloS onePubMeddocument of 10 observations

41.7 %The prevalence of Hepatitis B virus infection among patients presenting with jaundice in Kenya was 41.7%.

Kenyahépatite Bpublished 2023Frontiers in public healthPubMeddocument of 6 observations

27.9 %Among 208 HIV-infected ART-naïve adults in Kenya, 58 (27.9%) had previous hepatitis B virus (HBV) infection, as indicated by anti-HBc positivity.

Kenyahépatite B · VIH/sidapublished 2021PloS onePubMeddocument of 7 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.